NNOX Nano-X Imaging Ltd.

0.5950USD-3.31%Mkt Cap: 46.76M $P/E: —

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medica…

HeadlineSourceTime
Older
Nano-X (NNOX) Imaging Slashes Costs As Cash Clock Keeps Ticking

On September 9, Nano-X Imaging (NASDAQ:NNOX) held its second-quarter earnings call, and the message was blunt: growth is real, but so is the cash burn. Revenue climbed 37% year over year to $4.2 million for the quarter ended June 30, yet the company also booked a $40.7 million impairment charge and watched its cash pile […]

Insider Monkey
Nano-X Imaging (NNOX) Q2 2026 Earnings Call Transcript

CEO outlines restructuring plan and outsourced manufacturing shift to extend runway.

Motley Fool
Nano X Imaging Ltd (NNOX) (Q2 2026) Earnings Call Highlights: Revenue Surges 37% Amid Strategic ...

Nano X Imaging Ltd (NNOX) reports strong top-line growth driven by teleradiology services, while navigating a $40.7 million impairment and cash conservation efforts.

GuruFocus.com
Nanox Q2 Revenue Rises 37% as $40.7 Million Impairment Drives Wider GAAP Loss

Nanox (NASDAQ:NNOX) reported a 37% increase in second-quarter 2026 revenue to $4. 2 million, but its GAAP net loss widened to $55.

InvestorsHub
Nano-X Imaging Q2 Earnings Call Highlights

Nano-X Imaging (NASDAQ:NNOX) reported second-quarter 2026 revenue growth driven by its teleradiology, health IT and AI businesses, while recording a substantial non-cash impairment charge and outlining cost-reduction actions intended to extend its cash runway. Revenue for the quarter ended June 30

MarketBeat